Introduction
The process of protein N-glycosylation can be divided into two major steps, the assembly and transfer of pre-assembled core oligosaccharides from precursor dolichol pyrophosphate to Asn residues of nascent proteins in the endoplasmic reticulum (ER) followed by the subsequent processing of N-glycans in the Golgi apparatus. Within the Golgi lumen, the N-glycan undergoes further modifications by a series of glycosyltransferases to yield mature complex type N-glycans (Kornfeld and Kornfeld 1985) . The sugar substrates added onto the growing glycans are in the form of nucleotide sugars which are synthesized in the cytoplasm or nucleus. These substrates are then transported into the Golgi apparatus by a set of nucleotide-sugar transporters (NSTs).
NSTs are highly conserved type III transmembrane proteins. They usually contain six to 10 transmembrane domains linked by hydrophilic loops on both sides of the Golgi membrane (for reviews, see Hirschberg et al. 1998; Gerardy-Schahn et al. 2001; Handford et al. 2006) . CMP-sialic acid transporter (CST) represents one of the best-studied NSTs and is localized in the medial-trans Golgi (Zhao et al. 2006) . It contains 10 transmembrane domains with both the amino and carboxyl termini facing the cytosolic side of the Golgi membrane (Eckhardt et al. 1999 ). The CST functions as an antiporter that couples the import of CMP-sialic acid into the Golgi lumen and the export of CMP back to the cytosol (Abeijon et al. 1997; Hirschberg et al. 1998) . Early structure-function studies on CST involved the expression of murine CST in yeast followed by the analysis of the transport activity using Golgi-enriched vesicles prepared from the yeast (Berninsone et al. 1997) .
The roles of the N-and C-terminal cytosolic tails in CST localization and trafficking have been analyzed. The C-terminal tail of CST was found to be essential for its ER export and Golgi localization. Deletion of the last four amino acids (IIGV) of the C-terminal tail eliminated the export signals and prevented ER-to-Golgi translocation (Zhao et al. 2006) . The importance of highly conserved Gly residues within the transmembrane domains was revealed through the mutation of a Gly residue to different amino acids (Eckhardt et al. 1998) . Introduction of a G281D point mutation identified in UDP-galactose transporter (UGT)-deficient Lec8 CHO mutant into the homologous region of the CST also led to the inactivation of the transporter . The significance of the Gly residues in the transmembrane domains of the CST was further confirmed using an erythropoietin/isoelectric focusing (EPO/ IEF) assay system (Lim et al. 2008 ). Submolecular regions re- Fig. 1 . Insertion of GFP at three loops in CST affects its transport activity. (A) Thirteen CST-GFP fusion constructs were generated by overlap PCR. In each CST-GFP fusion construct, one GFP open reading frame with two linker peptides linked to its N-and C-termini was inserted in a different position of CST. The insert in CST-GFP1 is shown in detail as an example for how other CST-GFP fusion constructs were generated. Detailed insertion sites for all constructs are shown in Supplementary Table 1. (B) Wild-type CST (CST-WT) and different CST-GFP fusion constructs were co-transfected with an EPO expressing vector into MAR-11 cells. Two days after transfection, recombinant EPO produced in the conditioned media were analyzed by the EPO/IEF assay. CST-GFP4 and CST-GFP8 did not show any transport activity, while CST-GFP10 showed partial loss of activity. (C) Twenty-four hours after transfection, the Golgi complex was visualized using an anti-giantin antibody (red). The green fluorescence of GFP in CST-GFP fusions was observed under UV light. Top panel, HA-CST was used as a control, and anti-HA antibody staining is shown in green. Except for CST-GFP10 which did not show any green fluorescence of GFP, all other CST-GFP fusion proteins are colocalized with the Golgi marker, giantin.
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sponsible for the determination of substrate specificity were identified using a panel of CST-UGT chimera (Aoki et al. 2001) . Certain chimeric transporters with sequences obtained from both CST and UGT were able to transport both UDP-galactose and CMP-sialic acid. It was further demonstrated that transmembrane domain 7 of the CST is required for substrate specificity, whereas transmembrane domains 2 and 3 affect the efficiency of nucleotide-sugar transport (Aoki et al. 2003) .
Recently, we have developed a simple EPO/IEF assay for more sensitive structure-function analyses of CST. Recombinant EPO expressed in CST-deficient CHO MAR-11 cells completely lack sialic acid due to dysfunctional CST in MAR-11 cells. Co-expressing normal CST in MAR-11 cells restores the EPO sialylation pattern that is similar to the EPO produced by wild-type CHO cells. The mutant version of CST with defective transport activity was unable or only partially able to sialylate recombinant EPO as shown on the IEF gel (Lim et al. 2008) . This assay seems to be more sensitive than the lectin-based cell surface staining assay used in the assessment of CST and UGT activities in Lec2 and Lec8 cells (Aoki et al. 2001) .
In this study, we investigated the function of the hydrophilic loops of CST. Green fluorescent protein (GFP) was inserted into different loops of CST to study the function of each loop in CST. With this "GFP-insertion scan" we identified regions on three distinct loops of CST, the second and fourth lumenal and fourth cytosolic loops, which are essential for transport activity. A detailed mutagenesis analysis identified several highly conserved amino acids that are crucial for the transport activity of CST and UGT.
Results
In this report, an indirect measurement of the transport activity was employed. The activity of each mutant CST is assessed by measuring the incorporation of sialic acid into the EPO molecule produced in CST-null MAR-11 cells. With the EPO/IEF assay, we have clearly demonstrated a positive correlation between EPO sialylation and the amount of plasmid DNA that expresses CST used in the transfection (Lim et al. 2008) , suggesting that a higher CST level in the cells results in a higher degree of EPO sialylation. Similarly, a less active CST mutant will be unable to transport sufficient amount of CMP-sialic acid into the Golgi. As a result, the recombinant EPO will be poorly or not sialylated.
Insertion of GFP at three loops inactivates CST
To investigate the role of the hydrophilic loops in the CST, GFP was inserted into different positions of the CST ( Figure 1A) . A peptide linker, SGGGGS, flanked the N-and C-termini of the GFP to provide a certain degree of flexibility for GFP to fluoresce. For example, in CST-GFP1, an insert of -SGGGGS-(GFP)-SGGGGS-was incorporated into the CST protein between Ala 75 and Ser 76 ( Figure 1A ). All together, 13 CST-GFP fusion constructs were generated, each with a GFP inserted into a different position in the CST ( Figure 1A ). There were two reasons to insert GFP into the CST. First, with the GFP we can easily identify whether the CST-GFP fusion protein is stably expressed and is localized to the Golgi apparatus. Second, if a particular loop in the CST is important for its function, interruption of the loop with a GFP molecule which contains 239 amino acids would affect the activity of the transporter. The transport activity of each CST-GFP fusion protein was analyzed in the mutant MAR-11 cells. Recombinant EPO expressed in MAR-11 cells completely lacks sialic acid as these cells lack a functional CST. However, co-transfecting MAR-11 cells with a construct that expresses CST completely restores EPO sialylation in MAR-11 cells. The degree of sialylation of recombinant EPO can easily be compared by IEF/Western blot analysis (Lim et al. 2008) . A construct expressing EPO was co-transfected with each of the 13 CST-GFP fusion constructs into MAR-11 cells. Conditioned media from each transfection were harvested 48 h after transfection, and the sialylation patterns of recombinant EPO were analyzed by IEF. The results are shown in Figure 1B . The lane on the farthest left shows EPO produced in MAR-11 cells. Due to the lack of sialylation, the EPO was not resolved by IEF. The several bands observed in this lane could be the result of aggregation between unsialylated EPO. The lane under "CST-WT" shows the EPO produced by MAR-11 cells that were co-transfected with a construct encoding normal CST. The rest of the lanes show the sialylation patterns of EPO produced in MAR-11 cells that were co-transfected with respective CST-GFP fusion constructs as indicated. EPO molecules produced in MAR-11 cells co-transfected with CST-GFP4 and CST-GFP8 completely lack sialylation, suggesting that the GFP insertion in these two constructs has completely inactivated the CST ( Figure 1B) . One GFP insertion, CST-GFP10, has partially lost transport activity of CST. All other insertions did not affect the activity of CST. Given that these experiments were all carried out in the same MAR-11 mutant cells, all other factors that can affect the sialylation of recombinant EPO, such as galactosyltransferases and sialyltransferases, remain unchanged in all experiments. The only difference in each transfection lies in the CST-GFP constructs. Hence, the three loops that were interrupted by GFP in CST-GFP4, CST-GFP8 and CST-GFP10 play important roles in transporting CMP-sialic acid.
GFP-CST fusion proteins are localized to the Golgi apparatus Cells that were transfected with CST-GFP fusion constructs were analyzed under a fluorescent microscope. Cells transfected with all CST-GFP constructs, except CST-GFP10, clearly expressed the typical green fluorescence of GFP. The expressed CST-GFP fusion proteins are all localized to the Golgi as the green fluorescence overlaps with the Golgi marker, giantin (see Supplementary Figure 1 online). For a closer look at the cellular localization of the CST-GFPs, several images are enlarged and shown in Figure 1C . As a control, cells transfected with a HA-tagged CST (HA-CST) construct were stained with an anti-HA antibody. HA-CST is clearly localized to the Golgi as it is colocalized with a Golgi marker, giantin (top panel, Figure 1C ). CST-GFP2, CST-GFP4 and CST-GFP8 are expressed and clearly localized to the Golgi ( Figure 1C ), although the latter two failed to restore the sialylation of EPO in MAR-11 cells ( Figure 1B ). Among 13 CSTGFPs, only CST-GFP10 failed to show any fluorescence, and the reason is unknown. Overall, these data suggest that insertion of GFP into these loop regions of CST does not affect its Golgi localization. In addition, the intensity of the green fluo- rescence seems to be similar whether the GFP is inserted into the CST on the cytosolic side or on the Golgi lumen side. In two constructs, GFP was linked to the C-terminus of CST. In CST-GFP11, the N-terminus of GFP was directly fused to the C-terminus of CST. In CST-GFP12, a peptide linker, SGGGGS, was placed in between. The results suggest that linking GFP to the C-terminus of CST with (CST-GFP12) or without (CST-GFP11) a linker does not affect its Golgi localization ( Figure 1C ). CST-GFP12 was chosen to generate all the mutations in following experiments. As such, the expression and localization of CST-GFP can be easily observed.
Mutating the amino acids in the three loops in CST-GFP12 resulted in losing transport activity To confirm the results observed in the GFP insertion experiments, amino acids in the three loops, the second and fourth lumenal loops and the fourth cytosolic loop, were mutated in CST-GFP12 construct. Six tetra-Gly substitution (TGS) mutants were generated. In each of these constructs, four consecutive amino acids in a loop were substituted with four Gly residues. For example, in tetra-Gly substitution-1 (TGS-1), four amino acids in the second lumenal loop in CST-GFP12, 111 NLDA 114 , were substituted with four Gly residues ( Figure 2A ). Similarly, five more constructs were generated by substituting four consecutive amino acids in CST-GFP12 with four Gly residues. These constructs are TGS-2 ( 232 EIKE 235 ), TGS-3 ( 2 3 6 KGFF 2 3 9 ), TGS-4 ( 2 6 7 TDNI 2 7 0 ), TGS-5 ( 269 NIMK 272 ) and TGS-6 ( 271 MKGF 274 ). The amino acid residues in the parentheses indicate the substituted amino acids in each construct (Supplementary Table 1 ). To ensure that these six CST-GFP12 mutant proteins (TGS-1 to TGS-6) were stably expressed and localized to the Golgi apparatus, they were transiently expressed in MAR-11 cells. The Golgi apparatus were visualized with anti-giantin. As shown in Figure 2B , all six TGS mutants were expressed and colocalized with the Golgi marker giantin. The transport activity of these TGS mutants was analyzed with the EPO/IEF assay, and the results are shown in Figure 2C . The lane on the farthest left shows the unsialylated EPO produced by MAR-11 cells. The second lane shows EPO produced by MAR-11 cells that were co-transfected with CST-GFP12. Six other lanes show EPO produced by MAR-11 cells that were co-transfected with each of the six TGS mutants. With the exception of TGS-2, all TGS mutants showed no transport activity. The fact that mutant TGS-2 retained most of its transport activity explained why the transport activity was only partially lost in CST-GFP10. In CST-GFP10, the GFP was inserted into CST between I 233 and K 234 which is localized in the middle of tetrapeptide 232 EIKE 235 that was mutated in TGS-2. Therefore, GFP was not inserted into an important region in CST-GFP10. However, the GFP was inserted at a site that is close to a crucial region for activity ( 236 KGFF 239 that was mutated in TGS-3). All other TGS mutants completely abolished the transport activity in CST-GFP12 ( Figure 2C ). These results confirmed that these three loops are critical for the transport activity of CST.
To further narrow down the essential amino acids identified in the TGS mutants, we next replaced only two amino acids with Gly residues within the regions covered by the TGS mutants. For example, in di-Gly substitution-1 (DGS-1), two amino acids 112 LD 113 that are in the middle of the tetrapeptide 111 NLDA 114 (mutated in TGS-1) were substituted with two Gly residues. EPO/IEF results shown in Figure 2D suggest that mutating 112 LD 113 was enough to inactivate the transport activity of CST, suggesting that these two amino acids are essential for CST's activity. However, mutating only two amino acids in DGS-3 ( 238 FF 239 ) and DGS-4 ( 268 DN 269 ) failed to inactivate the transporter (Figure 2D ), suggesting that in these two regions mutating four (maybe three) amino acids is required in order to inactivate the transporter.
Lys
272 and Ile 270 in the fourth loop on the cytosolic side are crucial for CST activity To investigate the role of single amino acids in these glycine substitution (GS) regions, amino acid residues covered by the TGS mutants were each mutated to an Ala residue (Supplementary Table 1 ). Analyzing the IEF patterns of EPO produced by MAR-11 cells co-expressing the Ala mutant constructs reveals that mutation of Lys 272 to Ala caused CST-GFP12 to lose its activity completely ( Figure 3A ). All other Ala substitution mutants remained active. In a similar fashion, each of these amino acids was individually changed to a Gly residue to further analyze the impact of the side chain of each amino acid. Again, Lys 272 substitution with Gly also completely inactivated the transporter ( Figure 3B ). CST-GFP12 with its Lys 272 changed to Ala or Gly did not affect its stability or its Golgi localization ( Figure 3C ), suggesting that these two CST-GFP12 substitution mutants were properly expressed and localized to the Golgi. These results demonstrate that Lys 272 is essential for CST function. A closer analysis on Figure 3B revealed that changing Ile 270 to a Gly may have partially reduced the transport activity, although changing the same amino acid to Ala did not seem to obviously affect its activity ( Figure 3A) .
To further investigate the role of Lys 272 , it was also mutated to two other amino acids, Arg and His CST-GFP12. It was changed to Arg because Arg also has a positively charged side chain. Lys was changed to His because His is the amino acid found in the homologous position in human GDP-fucose transporter. The activities of these mutants were analyzed with the EPO/IEF assay. As shown in Figure 4A , CST-GFP12 with a Lys272Arg mutation is as active as the wild-type transporter. However, when Lys 272 was changed to a His residue, it completely inactivated the transporter. As shown in Figure 3B , the transporter lost partial activity when Ile 270 was changed to Gly. However, it did not seem to affect the transport activity when Ile 270 was changed to Ala ( Figure 3A) . These results suggest that the size of the side chain in Ile 270 may affect CST's activity. To confirm this hypothesis, Ile 270 was mutated to Thr, which has a hydroxyl group, but the size of the side chain is similar to that in Ile. Ile 270 was also mutated to Trp to enlarge the hydrophobic side chain. The transport activities of these mutants were analyzed using the EPO/IEF assay, and the results are shown in Figure 4B . Indeed, Ile270Thr mutant showed similar activity as the wild-type CST. The relative transport activity of these mutant constructs compared to the wild type are in the order of Ile270Trp < Ile270Gly < Ile270A-la < Ile270Thr < wild-type control. Therefore, the size of the side chain at this position does seem to have an impact on the activity of the transporter. These results further illustrate the sensitivity of the EPO/IEF assay.
The conserved Lys residue in UGT is also essential for its transport activity CST and UGT are highly related NSTs. The Lys 272 in CST is conserved in UGT (Lys 297 ). To investigate the function of Lys 297 in UGT, it was mutated to Arg, His, Ala and Gly in HA-tagged UGT (HA-UGT). The wild-type and the mutated UGTs were transiently transfected into the UGT-deficient Lec8 cells. The results from the EPO/IEF assay are shown in Figure 5 . Similar to CST, Lys 297 in UGT is indeed essential for its function. Unlike CST, UGT with a Lys297Arg mutation lost most of its activity. Similar to CST, substituting Lys297 in UGT with either His, Ala or Gly completely inactivates the transporter. The subcellular localization of the wild-type and mutant UGT was analyzed with an anti-HA antibody. The results showed that they are all expressed and shared similar localization (data not shown). ) in CST and the conserved Lys residue (Lys 297 ) in UGT are crucial for the transporter's activities and they are localized on a loop facing the cytosol, we examined whether this loop is involved in specific substrate recognition. Figure 6A shows the sequence alignment between Chinese hamster CST and UGT at the region flanking the critical Lys residue. It was observed that CSTs across different mammalian species shared the same conserved amino acid sequence (underlined) compared to the conserved sequence in UGTs. A chimeric transporter was made by replacing the underlined sequence of CST with the underlined sequence of UGT to give rise to a mutated CST (CSTmt). Similarly, a mutated UGT (UGTmt) was generated by replacing the underlined sequence of UGT with that of CST. Chimeric constructs were expressed in MAR-11 and Lec8 cells by transient expression. EPO/IEF assay subsequently showed that CSTmt successfully restored EPO sialylation in MAR-11 cells, suggesting that replacing the underlined region in CSTwith that from UGT did not affect the activity of CST ( Figure 6B ). However, the mutated UGT, UGTmt, has lost most of its transport activity as UGTmt failed to complement the genetic defect in Lec8 cells as shown in Figure 6C . These results suggest that the amino acids flanking the conserved Lys residue (Lys 297 ) in UGT are critical for its activity.
The role of highly conserved amino acids in the loop regions of CST and UGT on their transport activities Sequence alignment of CSTs, UGTs, UDP-GlcNAc transporters and GDP-fucose transporters from different mammalian species revealed that some amino acids are highly conserved, and several of them are located in the loop regions. These conserved amino acids in CST are shown in Figure 7A . To investigate whether any of these conserved amino acids are crucial for the activities of CST and UGT, each of these 10 amino acids was mutated to Gly in both CST and UGT. All the amino acid residues that were covered in TGS-1, TGS-3, TGS-4 and TGS-6 were changed to an Ala individually in CST-GFP12. As such, each mutant CST-GFP12 construct carries one amino acid substitution, for example, CST-GFP12-N111A. Each of the 16 mutated CST-GFP12 constructs were co-transfected with an EPO-expressing vector. The recombinant EPO produced in each transfection were analyzed by the IEF assay. The results show that the K272A mutation completely inactivated the transporter. (B) Each amino acid shown in (A) was mutated to Gly. The K272G mutation also completely inactivated the transporter. The I270G mutation partially inactivated the CST. (C) The two mutant versions of CST-GFP12, K272A and K272G show colocalization with the Golgi marker, giantin.
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EPO/IEF results showed that replacing most of these amino acids with Gly did not affect transport activity with two exceptions. As shown in Figure 7B , replacing Leu 136 in CST with Gly (L136G) completely inactivated the CST as it failed to sialylate EPO in MAR-11 cells. However, as shown in Figure 7C , UGT lost its activity when a different Leu (Leu 224 ), corresponding to Leu 199 in CST, was mutated to Gly as it failed to sialylate EPO in Lec8 cells. Partial loss of UGT activity was also observed when Ile 223 , corresponding to Val 198 in CST, was replaced with Gly. The results presented in this report are summarized in Figure 8 . We have identified Lys 272 and Leu 136 as the single amino acid residues on the hydrophilic loop regions required for transport activity of CST. Mutating either of these residues leads to a complete loss in CST activity as indicated by the subsequent loss of EPO sialylation on the EPO/IEF assay. On the lumenal side, two regions are also essential for CST's activity. Mutating 112 LD 113 to two Gly residues or mutating 267 TDNI 270 or 236 KGFF 239 to four Gly residues completely inactivated the transporter. In UGT, two amino acids, Lys 297 and Leu 224 , both on the cytosolic side, were identified as essential for its activity.
Discussion
It is essential to maintain sufficient amount of CMP-sialic acid in the Golgi lumen for proper sialylation of N-and O-linked glycans to occur. The degree of sialylation on recombinant EPO is positively correlated with the activity of CST in our IEF assay. While many factors, such as galactose transferase and sialyltransferase, can affect the overall sialylation of recombinant EPO, these were kept constant in our experiments as all these analyses were carried out in the same MAR-11 mutant cells. The only real difference in each transfection lies in the CST construct used. Therefore, the degree of sialylation on recombinant EPO directly reflects the activity of each CST construct.
Previous efforts to understand roles of single amino acid residues to the function of CST and UGT and their localization include analysis of point mutations found in CHO mutants Lec2 (Eckhardt et al. 1998 ) and Lec8 . With the 10 transmembrane domain model (Eckhardt et al. 1999 ) as a good estimate of the transporter topology (Caffaro and Hirschberg 2006) , importance of Gly residues in trans-695 Fig. 5 . Lys 297 in UGT is essential for UGT activity. Lys 297 in HA-UGT was mutated to Arg (K297R), His (K297H), Ala (K297A) and Gly (K297G). Each of the mutated HA-UGT constructs was co-transfected with an EPO vector into Lec8 cells. Recombinant EPO produced in each transfection was analyzed by the IEF assay. These results show that Lys 297 in UGT, similar to Lys 272 in CST, is an absolute requirement for its activity. Essential amino acid residues in the CST and UGT membrane domains has been studied. (Eckhardt et al. 1998; Lim et al. 2008) . Here, we have focused on the functional information of the hydrophilic loops of the CST and identified several residues crucial for transporter activity. A more detailed study will involve heterologous expression of these mutant CST and UGT constructs and reconstitution of transporters into proteoliposomes (Caffaro and Hirschberg 2006) to understand how these residues affect the transporter at the mechanisms level.
In this study, we seek to understand the function of different hydrophilic loops of the CST. The strategy employed in this work was to insert a GFP molecule into different loops to generate a panel of CST-GFP fusion proteins. The inserted GFP protein serves a dual purpose. First, the expression and localization of these CST-GFP fusion proteins in the cell can be easily analyzed by examining the green fluorescence of GFP. Second, insertion of GFP into a loop disrupts the structure of that particular loop which may result in loss of transport activity if the loop is crucial for its activity. The fusion protein constructs were generated based on the 10 transmembrane domain model of CST (Eckhardt et al. 1999) . GFP has been used numerous times in literature to follow the localization of a protein of interest mostly by fusing GFP either to the N-terminus or the C-terminus of the protein. GFP has previously been inserted into an internal loop of G protein α subunit in living cells to visualize the localization of the protein (Hughes et al. 2001 ). To insert a GFP molecule that contains 239 amino acids into a loop of a CST molecule that contains only 336 amino acids may have a tremendous impact on the function of CST by possibly disrupting the topology of the CST. Immunofluorescence studies of the CST-GFP fusion proteins were carried out, and the activity of the CST-GFP was assayed through EPO/IEF assay in MAR-11 cells. Surprisingly, the insertion of GFP generally does not affect the localization and activity. Immunofluorescence staining results indicate that the fusion proteins are still localized to the Golgi (Supplementary Figure 1 and Figure 1C ). Our functional analysis using the EPO/IEF assay revealed that insertion of GFP at three loops affected the activity of CST. These are the second and fourth lumenal loops and the fourth cytosolic loop of CST. Among the 13 CST-GFP fusion proteins, only CST-GFP10 failed to show any fluorescence, and the reason for this remains unknown. However, EPO expressed in MAR-11 cells that were co-transfected with this construct was partially sialylated, suggesting that inserting GFP into the fourth lumenal loop partially inactivated the transporter ( Figure 1B) . Our results are in good agreement with a previous report which suggests that the second lumenal and fourth cytosolic loops of CST play crucial roles because epitope insertions into these loops inactivated transport activity (Eckhardt et al. 1999) .
Three loops of the CST, second and fourth lumenal loops and fourth cytosolic loop, were confirmed to be essential for its activity by performing Gly substitution experiments. Single amino acid substitution experiments showed that Lys 272 on the fourth 696 The sequence alignment between CST and UGT at the region flanking the critical Lys residue is shown. To investigate the role of this region for substrate recognition, the underlined regions were exchanged between CST and UGT to generate CSTmt (CST containing the underlined fragment exchanged from UGT) and UGTmt (UGT containing the underlined fragment exchanged from CST). The arrow indicates the conserved Lys residue. (B) Constructs expressing CST, UGT, CSTmt or UGTmt were co-transfected with an EPO-expressing vector into MAR-11 cells. Recombinant EPO produced in each transfection was analyzed by IEF. Results show that CSTmt was able to restore the defect in MAR-11 cells. Exchanging the underlined region with UGT did not affect the activity of CST. (C) The same constructs shown in (B) were transfected into Lec8 cells. The results show that UGTmt, which is UGT exchanged for the underlined region with CST, lost most of its activity.
KF Chan et al. Fig. 7 . The role of highly conserved amino acid residues in the loop regions in CST and UGT. (A) Ten amino acids in the loop regions of CST were found to be highly conserved among CSTs, UGTs, UDP-GlcNAc transporters and GDP-fucose transporters from different mammalian species. (B) Ten CST-GFP12 mutants were generated by replacing each of the conserved amino acids with a Gly residue. Each of the CST-GFP12 mutants was co-transfected with an EPO vector into MAR-11 cells. Recombinant EPO produced from each transfection was analyzed by IEF. The results show that mutation of Leu 136 (L136G) in CST results in complete loss of its activity. Mutations in any other conserved amino acids did not affect the activity of the CST. (C) Similarly, 10 HA-UGT mutants were generated by replacing each of the conserved amino acids with a Gly residue. Transport activity of each UGT mutant was analyzed in Lec8 cells, and the results show that mutating Leu 224 to a Gly (L224G) in UGT completely inactivated the transporter. Ile 223 to Gly mutation (I223G) in UGT results in a partial loss of activity. Mutating any other conserved amino acids in UGT did not affect its activity.
Essential amino acid residues in the CST and UGT cytosolic loop of CST was absolutely required for its function. As CST and UGT are highly homologous NSTs, the conserved Lys residue in UGT (Lys 297 ) was also mutated by site-directed mutagenesis. Indeed, mutating Lys 297 in UGT completely inactivated the transporter. Single Gly substitution experiments also revealed that Ile270 in CST may play an important role as Ile270Gly mutation resulted in a partial loss of its activity.
Sequence alignment analysis of CSTs, UGTs, GlcNAc transporters and GDP-fucose transporters from different mammalian species revealed 10 highly conserved amino acids in the loop regions. Mutagenesis studies revealed that substituting Leu 136 in CST with Gly completely inactivated the transporter. However, mutating the conserved Leu residue in UGT (Leu 160 ) did not affect the activity of UGT. In addition, UGT lost its activity when a different Leu residue (Leu 224 ) was mutated to Gly, whereas mutating the corresponding Leu residue in CST (Leu 199 ) did not affect the activity of CST. The functional importance of Leu 136 in CST was not "detected" by the "GFP insertion scan" as insertion of GFP in the second loop on the cytosolic side (CST-GFP2) did not change the activity of CST. This may be due to the fact that the exact insertion site of GFP in CST-GFP2 is between Thr 139 and Leu 140 , which is several amino acids away from Leu 136 . This finding implies that, while the GFP insertion approach provides a rapid scan of the loops of the transporter, a negative result cannot rule out the possibility that essential amino acids exist in that loop.
In previous studies, the assessment of UGT and CST activities was achieved by using UGT-deficient Lec8 cells and CSTdeficient Lec2 cells. Flourescein isothiocyanate-conjugated plant lectins such as GS-II and PNA were used to stain the cells to verify the changes at the termini of cell surface glycoconjugates (Aoki et al. 2001; Aoki et al. 2003) . Although this method is suitable for analyzing the activities of UGT and CST in Lec8 or Lec2 background, it is difficult to compare two CST mutants that have only lost partial activity. Our EPO/IEF assay has clearly shown its advantage over the "lectin-staining" method as it precisely showed the differences in CST activity in the form of EPO sialylation pattern ( Figures  1B, 3B and 4B ). As we have previously shown, the degree of sialylation of recombinant EPO produced in MAR-11 cells is dependent on the amount of CST cDNA construct used in the transfection (Lim et al. 2008 ). Reduced CST activity by mutation will result in decreased amount of CMP-sialic acid in the Golgi lumen which will subsequently affect the degree of EPO sialylation.
Mutation in human CST gene has been reported, and it is responsible for congenital disorder of glycosylation type II (Martinez-Duncker et al. 2005) . Deficiency of functional GDP-fucose transporter leads to complete absence of fucose on cell surface glycoproteins and is responsible for leukocyte adhesion deficiency II (Lühn et al. 2001; Lübke et al. 2001; Hellbusch et al. 2007 ). This was further confirmed from the mouse knockout studies where GDP-fucose transporter-deficient mice exhibited the symptom of congenital disorder of glycosylation IIc/leukocyte adhesion deficiency II (Hellbusch et al. 2007 ). These observations clearly highlighted the need for a better understanding of the functional mechanisms of these specific NSTs.
In summary, using the GFP insertion strategy, we discovered that three specific hydrophilic loops of CST play crucial roles for its activity. Mutagenesis experiments identified the responsible amino acids in each of the three loops. Mutating Lys 272 alone completely inactivates CST. Mutating the conserved Lys residue in UGT results in a complete inactivation of UGT. A sequence alignment revealed several highly conserved amino acids in the loop region. Mutagenesis experiments showed that Leu 136 in CST is essential for its activity. Interestingly, mutating a different conserved amino acid in UGT (Leu 224 ) results in a complete inactivation of UGT. These results provide new insights into the structural and functional relationship of CST and UGT.
Materials and methods
Cell culture CHO MAR-11 cells were cultured in Dulbecco's modified Eagle's medium (DMEM, Invitrogen, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS) (Invitrogen, Grand Island, N.Y.) , at 37°C with 5% CO 2 . CHO Lec8 cells were a kind gift from Dr. Pamela Stanley (Albert Einstein College of Medicine, NY) and were cultured in α-MEM supplemented with proline (40 mg/L) (Invitrogen, Grand Island, NY) containing 10% FBS, at 37°C with 5% CO 2 .
Constructs to express CST-GFP fusion proteins
To investigate the role of each hydrophilic loop in the CST, GFP was inserted into different loops of the Chinese hamster CST (GenBank accession number: Y12074) as shown in Figure 1A . A linker peptide, SGGGGS, was placed at both the N-terminus and C-terminus of the GFP, acting as two spacers between the CST and the GFP. A total of 13 CST-GFP fusion constructs were generated, each with a GFP flanked by two linker peptides inserted into different positions of the CST ( Figure 1A) . Please refer to Supplementary Table 1 for exact insertion sites. The constructs were generated by overlap polymerase chain reaction (PCR). Different mutations were later introduced into one of the CST-GFP fusion proteins, CST-GFP12, either by overlap PCR or by site-directed mutagenesis using the Site-Directed Mutagenesis Kit (Stratagene, Cedar Creek, TX). All the CST-GFP fusion constructs and mutated CST-GFP12 were cloned into the pcDNA3.1 vector between the EcoR I and Xba I sites. In order to ensure same translation efficiency, a Kozak sequence (GCCACCATG) was to two Gly residues also inactivated CST, whereas mutating either one of these two amino acids did not affect its activity. added upstream of the translation start codon in each construct. A construct that expresses HA-CST by adding a HA-tag to the N-terminal of CST was also cloned into the pcDNA3.1 vector.
Construction of Chinese hamster UGT expression vector
The open reading frame of Chinese hamster UGT (GenBank accession number: AF299335) was cloned into the pcDNA3.1 vector. This version of UGT is localized to the ER (Kabuss et al. 2005) . A HA-tag was added to the N-terminus of the UGT for cellular localization. Different UGT mutants were created by mutagenizing this HA-UGT construct using the Site-Directed Mutagenesis Kit (Stratagene). All the constructs generated in this work are summarized in Supplementary  Table 1 .
Transient expression of human EPO in CHO MAR-11 cells cDNA encoding the open reading frame of human EPO was cloned into pcDNA3.1. Before transfection, 5 × 10 5 CHO MAR-11 cells were seeded into each well of six-well plates and cultured overnight. The EPO expression construct was transiently transfected into mutant MAR-11 cells using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) according to manufacturer's protocol. In each transfection, 4 μg plasmid DNA and 10 μl Lipofectamine 2000 reagent were added to each well containing 2 ml of medium (DMEM, 10% fetal bovine serum). Forty-eight hours after the transfection, the media was collected and the EPO protein in the media analyzed by IEF/Western blot as described previously (Lim et al. 2008) . To analyze the activity of CST-GFP fusion proteins, 2 μg plasmid DNA encoding human EPO and 2 μg plasmid DNA encoding a CST-GFP fusion protein or a mutant construct of CST-GFP12, were mixed and transfected into MAR-11 cells. For analysis of the UGT protein activity, 2 μg plasmid DNA encoding human EPO and 2 μg plasmid DNA encoding UGT protein were mixed and transfected into Lec8 cells.
IEF analysis of recombinant EPO
The sialylation patterns of EPO in different samples were analyzed by IEF followed by Western blot modified from previously published protocols (Lasne et al. 2002; Schriebl et al. 2006) . The pH range for IEF was from 3 to 10. To ensure equal loading for IEF, the concentrations of EPO in different samples were predetermined by enzyme-linked immunosorbent assay using an EPO ELISA kit (Roche, Mannheim, Germany).
Immunofluorescence staining MAR-11 cells were plated on glass coverslips and grown overnight before transfection. Constructs expressing different CST-GFP fusion proteins or CST-GFP12 with different mutations were transfected into MAR-11 cells. Immunofluorescent staining of Golgi apparatus with anti-giantin was performed according to previously published methods (Lim et al. 2008) . Briefly, 24 h after transfection, cells were fixed in 4% paraformaldehyde, permeabilized with 0.1% Triton X-100 (Sigma, St. Louis, MO), and blocked in 10% normal goat serum (Invitrogen, Carlsbad, CA) for 30 min. Cells were then incubated with a 1:100 dilution of anti-HA monoclonal antibody (Sigma) and a 1:200 dilution of rabbit anti-giantin serum (Abcam, Cambridge, UK) in phosphate-buffered saline (PBS) with 1% bovine serum albumin (BSA) for 1 h. Cells were washed three times with PBS and subsequently incubated with goat anti-mouse antibody conjugated with Alexa Fluor 594 and goat anti-rabbit antibody conjugated with Alexa Fluor 488 (Invitrogen) in PBS with 1% BSA for 1 h. Cells were washed three times with PBS before mounting on glass slides with Prolong Gold antifade mounting medium (Invitrogen, Eugene, OR). Fluorescence images were obtained using a Carl Zeiss META confocal microscope. For cells that were transfected with CST-GFP fusion constructs, staining step with the anti-HA monoclonal antibody was omitted.
Supplementary data
Supplementary data for this article is available online at http:// glycob.oxfordjournals.org/.
